Related Experiment Videos
[Necrotizing scleritis--successful treatment with solcoseryl]
1Oddziału Okulistycznego Szpitala Miejskiego, Gdyni, Poland.
Klinika Oczna
|July 1, 1992
Summary
Solcoseryl treatment effectively healed necrotising scleritis in a patient with osseous rheumatism. This intravenous therapy accelerated scleral healing, preventing complications and preserving visual ability.
Area of Science:
- Ophthalmology
- Rheumatology
- Pharmacology
Background:
- Necrotising scleritis is a severe inflammatory condition affecting the sclera.
- Osseous rheumatism can present with ocular manifestations, including scleritis.
- Limited treatment options exist for severe necrotising scleritis.
Observation:
- A single case of necrotising scleritis associated with osseous rheumatism was reported.
- The patient received intravenous Solcoseryl for 20 days.
- The treatment was well-tolerated by the patient.
Findings:
- Intravenous Solcoseryl demonstrated a positive effect on scleral healing.
- The treatment expedited the healing process of the sclera.
- No secondary complications were observed during the treatment period.
Implications:
- Solcoseryl may be a viable therapeutic option for necrotising scleritis.
- Early intervention with Solcoseryl can preserve visual function in patients with scleritis.
- Further research is warranted to confirm the efficacy and safety of Solcoseryl in larger cohorts.